Cholesterol, LDL - Drug effects
Research News and Information

Sunday, November 22, 2009

Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.

Nov 2009 OBJECTIVES: Our aim was to determine the effects of high-dose (2 g) nicotinic acid (NA) on progression of atherosclerosis and measures of vascular function. BACKGROUND: NA raises high-density lipoprotein cholesterol (HDL-C) and reduces low-density ... Read more...

Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation.

4 Oct 2009 That statins should be prescribed for patients before hospital discharge after an episode of acute coronary syndrome (ACS) is a Level of Evidence: 1A recommendation of the American College of Cardiology/American Heart Association Joint Task Force. ... Read more...

Statins in acute coronary syndromes: do the guideline recommendations match the evidence?

4 Oct 2009 On the basis of the evidence obtained from observational studies, randomized controlled trials and their meta-analyses, current guidelines recommend initiating high-dose statin therapy pre-discharge regardless of the baseline low-density lipoprotein ... Read more...

Latest indexed articles for 'Cholesterol, LDL - Drug effects'

These are the very latest articles for this heading:

• Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging. Nov 2009
• Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. Nov 2009
• Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation. 4 Oct 2009
• Statins in acute coronary syndromes: do the guideline recommendations match the evidence? 4 Oct 2009
• Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. 29 Sep 2009
• Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study. 29 Sep 2009
• Mostly plants. 29 Sep 2009
• Effects of plant-based diets on plasma lipids. 29 Sep 2009
• Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. 17 Aug 2009
• Advances in the medical treatment of diabetic retinopathy. 30 Jul 2009
• Alternate day dosing of rosuvastatin: potential usefulness in statin-intolerant patients. 30 Jul 2009
• Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong. 30 Jul 2009
• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. 2 Jul 2009
• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. 2 Jul 2009
• Population analyses of atorvastatin clearance in patients living in the community and in nursing homes. 29 Jun 2009
• Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. 29 Jun 2009
• Drug prevention of hypertension. Up to a point. 27 Jun 2009
• [Impact of lipid lowering therapy on liver function] 26 Jun 2009
• Reducing morbidity and mortality in high risk patients with statins. 5 Jun 2009
• Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment. 30 May 2009

See a longer list of these articles.

Technical information about 'Cholesterol, LDL'

Definition: Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.

Registry Number: 0

Descriptor UI: D008078

Alternative terms: Cholesterol, LDL; Low Density Lipoprotein Cholesterol; beta-Lipoprotein Cholesterol; Cholesterol, beta-Lipoprotein; beta Lipoprotein Cholesterol; LDL Cholesterol; Cholesteryl Linoleate, LDL; LDL Cholesteryl Linoleate;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532.515.500; D10.570.938.208.275; D12.776.521.550.500;

History Note: 2007 (1985)